## Third-Generation vs First-Generation Cephalosporins: Spectrum Comparison ### Generational Progression in Cephalosporin Development **Key Point:** As cephalosporin generations advance, there is a progressive shift from gram-positive dominance (1st gen) toward gram-negative dominance (3rd gen), with a trade-off in gram-positive coverage. ### Comparative Spectrum Table | Feature | 1st Generation | 2nd Generation | 3rd Generation | |---------|---|---|---| | **Gram-positive coverage** | Excellent | Good | Reduced (but adequate) | | **Gram-negative coverage** | Poor | Improved | Excellent | | **Anaerobic coverage** | Minimal | Variable | Minimal (except cefoxitin) | | **CNS penetration** | Poor | Poor | **Excellent** (ceftriaxone, cefotaxime) | | **β-lactamase resistance** | Moderate | Better | Much better | | **Clinical use** | Skin/soft tissue, UTI | Mixed infections | Serious gram-negative, meningitis | ### Structural Basis for Spectrum Shift **High-Yield:** Third-generation cephalosporins have: - Enhanced penetration of gram-negative outer membrane due to improved porin binding - Reduced affinity for gram-positive PBPs (penicillin-binding proteins) - Better blood-brain barrier penetration (especially ceftriaxone, cefotaxime) - Greater resistance to chromosomal and plasmid-mediated β-lactamases ### Clinical Pearl: The Trade-Off **Clinical Pearl:** While 3rd-generation cephalosporins excel against gram-negative organisms and provide CNS coverage, they are NOT the first choice for pure gram-positive infections (e.g., uncomplicated cellulitis). First-generation cephalosporins (cephalexin, cefazolin) remain preferred for such cases due to superior gram-positive activity and lower cost. ### Mnemonic **GEN-1 → GRAM+; GEN-3 → GRAM− & BRAIN** — First-generation favors gram-positive; third-generation favors gram-negative and crosses blood-brain barrier. [cite:Harrison 21e Ch 143]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.